PCRX Operating Cash Flow Growth
Pacira Biosciences Inc · Operating Cash Flow Growth
PCRX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported39.50%period ending
PCRX TTM Cash from Operations YoY % (-30.31% → 39.50%)
Year-over-year change
High-resolution chart · PNG
PCRX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 39.5025% | |
| -19.0797% | |
| -19.7451% | |
| -30.6141% | |
| -30.7863% | |
| -4.8071% | |
| 22.4638% | |
| 36.7125% | |
| 31.9316% | |
| 38.1643% | |
| 6.4533% | |
| 17.9119% | |
| 2.2438% | |
| -7.4702% | |
| 15.5564% | |
| -15.229% | |
| 11.9864% | |
| 74.1909% | |
| 63.201% | |
| 165.0998% | |
| 269.2756% | |
| 13.2133% | |
| 9.2343% | |
| -14.5316% | |
| -45.6536% | |
| 33.0034% | |
| 44.3012% | |
| 47.6773% | |
| 154.9753% | |
| 264.8641% | |
| 174.7821% | |
| 144.9102% | |
| -23.0953% | |
| -58.7479% | |
| -46.8359% | |
| -45.0708% | |
| 34.7025% | |
| 44.1179% | |
| 15.3711% | |
| 32.7046% | |
| -22.0327% | |
| -17.3171% | |
| 13.8482% | |
| 304.2085% | |
| 346.387% | |
| 189.8574% | |
| 158.9342% | |
| 110.6306% | |
| 78.7486% | |
| 48.5295% | |
| 38.3773% | |
| -2.7729% | |
| -10.3798% | |
| -48.9609% | |
| -126.2258% | |
| -93.3627% | |
| -94.715% | |
| -76.3207% | |
| -24.5981% | |
| -60.6725% | |
| -30.3137% |